Literature DB >> 20946988

A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.

Jonghwan Kim1, Andrew J Woo, Jianlin Chu, Jonathan W Snow, Yuko Fujiwara, Chul Geun Kim, Alan B Cantor, Stuart H Orkin.   

Abstract

c-Myc (Myc) is an important transcriptional regulator in embryonic stem (ES) cells, somatic cell reprogramming, and cancer. Here, we identify a Myc-centered regulatory network in ES cells by combining protein-protein and protein-DNA interaction studies and show that Myc interacts with the NuA4 complex, a regulator of ES cell identity. In combination with regulatory network information, we define three ES cell modules (Core, Polycomb, and Myc) and show that the modules are functionally separable, illustrating that the overall ES cell transcription program is composed of distinct units. With these modules as an analytical tool, we have reassessed the hypothesis linking an ES cell signature with cancer or cancer stem cells. We find that the Myc module, independent of the Core module, is active in various cancers and predicts cancer outcome. The apparent similarity of cancer and ES cell signatures reflects, in large part, the pervasive nature of Myc regulatory networks.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946988      PMCID: PMC3018841          DOI: 10.1016/j.cell.2010.09.010

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  52 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex.

Authors:  Yong Cai; Jingji Jin; Chieri Tomomori-Sato; Shigeo Sato; Irina Sorokina; Tari J Parmely; Ronald C Conaway; Joan Weliky Conaway
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

3.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

4.  Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells.

Authors:  Jonghwan Kim; Alan B Cantor; Stuart H Orkin; Jianlong Wang
Journal:  Nat Protoc       Date:  2009-03-26       Impact factor: 13.491

5.  The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.

Authors:  S B McMahon; M A Wood; M D Cole
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  The p400 complex is an essential E1A transformation target.

Authors:  M Fuchs; J Gerber; R Drapkin; S Sif; T Ikura; V Ogryzko; W S Lane; Y Nakatani; D M Livingston
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

7.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

8.  Module map of stem cell genes guides creation of epithelial cancer stem cells.

Authors:  David J Wong; Helen Liu; Todd W Ridky; David Cassarino; Eran Segal; Howard Y Chang
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

9.  Role of the murine reprogramming factors in the induction of pluripotency.

Authors:  Rupa Sridharan; Jason Tchieu; Mike J Mason; Robin Yachechko; Edward Kuoy; Steve Horvath; Qing Zhou; Kathrin Plath
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

10.  Opposing microRNA families regulate self-renewal in mouse embryonic stem cells.

Authors:  Collin Melton; Robert L Judson; Robert Blelloch
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962

View more
  365 in total

1.  Two-factor reprogramming of somatic cells to pluripotent stem cells reveals partial functional redundancy of Sox2 and Klf4.

Authors:  A Nemajerova; S Y Kim; O Petrenko; U M Moll
Journal:  Cell Death Differ       Date:  2012-04-27       Impact factor: 15.828

2.  Epigenetic reprogramming of Myc target genes.

Authors:  Stefano Amente; Luigi Lania; Barbara Majello
Journal:  Am J Cancer Res       Date:  2011-02-06       Impact factor: 6.166

3.  Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.

Authors:  Jennifer R Brown; Megan Hanna; Bethany Tesar; Lillian Werner; Nathalie Pochet; John M Asara; Yaoyu E Wang; Paola Dal Cin; Stacey M Fernandes; Christina Thompson; Laura Macconaill; Catherine J Wu; Yves Van de Peer; Mick Correll; Aviv Regev; Donna Neuberg; Arnold S Freedman
Journal:  Clin Cancer Res       Date:  2012-05-23       Impact factor: 12.531

Review 4.  Cancer/testis antigens and urological malignancies.

Authors:  Prakash Kulkarni; Takumi Shiraishi; Krithika Rajagopalan; Robert Kim; Steven M Mooney; Robert H Getzenberg
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

5.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

6.  Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Virology       Date:  2016-09-22       Impact factor: 3.616

7.  KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

Authors:  Alexandros Tzatsos; Polina Paskaleva; Francesco Ferrari; Vikram Deshpande; Svetlana Stoykova; Gianmarco Contino; Kwok-Kin Wong; Fei Lan; Patrick Trojer; Peter J Park; Nabeel Bardeesy
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 8.  Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Authors:  Dingxiao Zhang; Dean G Tang; Kiera Rycaj
Journal:  Semin Cancer Biol       Date:  2018-05-09       Impact factor: 15.707

9.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Authors:  Michael L Beshiri; Katherine B Holmes; William F Richter; Samuel Hess; Abul B M M K Islam; Qin Yan; Lydia Plante; Larisa Litovchick; Nicolas Gévry; Nuria Lopez-Bigas; William G Kaelin; Elizaveta V Benevolenskaya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

10.  Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.

Authors:  Daichi Inoue; Jiro Kitaura; Katsuhiro Togami; Koutarou Nishimura; Yutaka Enomoto; Tomoyuki Uchida; Yuki Kagiyama; Kimihito Cojin Kawabata; Fumio Nakahara; Kumi Izawa; Toshihiko Oki; Akie Maehara; Masamichi Isobe; Akiho Tsuchiya; Yuka Harada; Hironori Harada; Takahiro Ochiya; Hiroyuki Aburatani; Hiroshi Kimura; Felicitas Thol; Michael Heuser; Ross L Levine; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.